Should You Pick Johnson & Johnson Stock After A 6% Fall In A Month Despite Upbeat Q3?
Johnson & Johnson (NYSE: JNJ) reported its Q3 results last week, with revenues and earnings beating the street estimates.
Johnson & Johnson (NYSE: JNJ) reported its Q3 results last week, with revenues and earnings beating the street estimates.
What's Your Reaction?
